Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1978 1
1981 2
1982 1
1983 2
1984 6
1985 1
1986 3
1987 5
1988 7
1989 4
1990 4
1991 3
1992 2
1993 5
1994 2
1995 5
1996 6
1997 5
1998 4
1999 4
2000 7
2001 8
2002 6
2003 9
2004 6
2005 9
2006 9
2007 12
2008 7
2009 9
2010 6
2011 7
2012 6
2013 5
2014 2
2015 4
2016 2
2017 8
2018 1
2019 8
2020 3
2021 2
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

206 results

Results by year

Filters applied: . Clear all
Page 1
Vedolizumab as induction and maintenance therapy for ulcerative colitis.
Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A; GEMINI 1 Study Group. Feagan BG, et al. N Engl J Med. 2013 Aug 22;369(8):699-710. doi: 10.1056/NEJMoa1215734. N Engl J Med. 2013. PMID: 23964932 Free article. Clinical Trial.
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis.
Sands BE, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Colombel JF, Törüner M, Jonaitis L, Abhyankar B, Chen J, Rogers R, Lirio RA, Bornstein JD, Schreiber S; VARSITY Study Group. Sands BE, et al. N Engl J Med. 2019 Sep 26;381(13):1215-1226. doi: 10.1056/NEJMoa1905725. N Engl J Med. 2019. PMID: 31553834 Clinical Trial.
Guidelines for prevention of NSAID-related ulcer complications.
Lanza FL, Chan FK, Quigley EM; Practice Parameters Committee of the American College of Gastroenterology. Lanza FL, et al. Am J Gastroenterol. 2009 Mar;104(3):728-38. doi: 10.1038/ajg.2009.115. Epub 2009 Feb 24. Am J Gastroenterol. 2009. PMID: 19240698
Vedolizumab as induction and maintenance therapy for Crohn's disease.
Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A; GEMINI 2 Study Group. Sandborn WJ, et al. N Engl J Med. 2013 Aug 22;369(8):711-21. doi: 10.1056/NEJMoa1215739. N Engl J Med. 2013. PMID: 23964933 Free article. Clinical Trial.
Malabsorption testing: a review.
Ginsburg PM, Janefalkar P, Rubin DT, Ehrenpreis ED. Ginsburg PM, et al. Curr Gastroenterol Rep. 2000 Oct;2(5):370-7. doi: 10.1007/s11894-000-0036-6. Curr Gastroenterol Rep. 2000. PMID: 10998664 Review.
Encouraging New Uses for Old Drugs.
Sachs RE, Ginsburg PB, Goldman DP. Sachs RE, et al. Among authors: ginsburg pb. JAMA. 2017 Dec 26;318(24):2421-2422. doi: 10.1001/jama.2017.17535. JAMA. 2017. PMID: 29204602 No abstract available.
206 results